In this study, the abnormal gene expression patterns and mutational landscape of CRC were constructed and a range of targeted antigens, including THBS2, FSTL3, TNNT1, BGN, CTHRC1, and NOX4 were identified as promising mRNA vaccine candidates. This evidence concerns the gene THBS2 and colorectal carcinoma.